APPLIED MED RES LTD has a total of 21 patent applications. Its first patent ever was published in 1988. It filed its patents most often in EPO (European Patent Office), New Zealand and Australia. Its main competitors in its focus markets pharmaceuticals are ITF RES PHARMA S L U, REPOS PHARMA AB and HEART METABOLICS LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 3 | |
#2 | New Zealand | 3 | |
#3 | Australia | 2 | |
#4 | China | 2 | |
#5 | Israel | 2 | |
#6 | Russian Federation | 2 | |
#7 | Egypt | 1 | |
#8 | Finland | 1 | |
#9 | Greece | 1 | |
#10 | Japan | 1 | |
#11 | Republic of Korea | 1 | |
#12 | Philippines | 1 | |
#13 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Cohen Michael | 18 |
#2 | Majkl Kokhen | 1 |
Publication | Filing date | Title |
---|---|---|
GR910100020A | Compositions and method for the menopause symptoms | |
EG19606A | Compositions and method for alleviating menopausal symptoms | |
IL96926D0 | Pharmaceutical compositions for alleviating post-menopausal symptoms comprising melatonin and a least one estrogen and/ or androgen | |
NZ234210A | Composition comprising melatonin and an androgen | |
IL94411A | Compositions comprising an analog of melatonin in combination with progestogen and/or estrogen for effecting contraception | |
NZ233697A | Contraceptive composition comprising a melatonin analogue and a progestogen and/or an estrogen | |
RU2067001C1 | Method for reducing risk to acquire mammary gland carcinoma |